We are live on ! Find out more
PALI icon

Palisade Bio
PALI

5 hedge funds and large institutions have $19M invested in Palisade Bio in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $551K | Put options by funds: $380K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

44% less funds holding

Funds holding: 9 → 5 (-4)

47% less capital invested

Capital invested by funds: $35.5M → $19M (-$16.6M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
5
Holders Change
-4
Holders Change %
-44.44%
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
–
Increased
–
Reduced
–
Closed
4
Calls
$551K
Puts
$380K
Net Calls
+$171K
Net Calls Change
+$362K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
-$1.84M
2
Goldman Sachs
Goldman Sachs
New York
-$1.84M
3
Northern Trust
Northern Trust
Illinois
-$1.84M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.84M
5
TCIM
TIAA CREF Investment Management
New York
-$337K
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
26
PNC Financial Services Group
Pennsylvania
$50K – – –
GT
27
Greenleaf Trust
Michigan
$49K – – –
JPTCCM
28
J.P. Turner & Co Capital Management
Georgia
$46K – – –
LTFS
29
Ladenburg Thalmann Financial Services
Florida
$45K – – –
NP
30
NorthRock Partners
Minnesota
$44K – – –
MFS
31
MSI Financial Services
Massachusetts
$37K – – –
PAM
32
Panagora Asset Management
Massachusetts
$37K – – –
DC
33
Davenport & Co
Virginia
$35.4K – – –
Morgan Stanley
34
Morgan Stanley
New York
$34K – – –
ECM
35
EagleClaw Capital Management
Massachusetts
$26K – – –
UBS Group
36
UBS Group
Switzerland
$22K – – –
BA
37
BlackRock Advisors
Delaware
$21K – – –
Commonwealth Equity Services
38
Commonwealth Equity Services
Massachusetts
$21K – – –
RCAG
39
Rehmann Capital Advisory Group
Michigan
$21K – – –
PAG
40
Private Advisor Group
New Jersey
$20K – – –
GC
41
Guggenheim Capital
Illinois
$19K – – –
FWCM
42
First Western Capital Management
California
$18K – – –
VKH
43
Virtu KCG Holdings
New York
$18K – – –
Creative Planning
44
Creative Planning
Kansas
$17K – – –
NG
45
Northstar Group
New York
$15K – – –
PA
46
Pinnacle Associates
New York
$15K – – –
BIM
47
BlackRock Investment Management
Delaware
$14K – – –
SG Americas Securities
48
SG Americas Securities
New York
$14K – – –
FHC
49
First Heartland Consultants
Missouri
$12K – – –
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$10K – – –
1
2
3

PALI Hedge Fund Activity: Q3 2015 in Review

5 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2015, worth a combined $19M — down 47% from $35.5M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of PALI and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Credit Suisse, exiting entirely with an estimated $1.84M sold.

  • 5 institutional investors held Palisade Bio (PALI) as of Q3 2015, down from 9 in Q2 2015.
  • Funds reported $19M of Palisade Bio stock for Q3 2015, down 47% quarter-over-quarter.
  • 0 funds opened new Palisade Bio positions in Q3 2015 and 4 closed out, a net change of -4 holders.
  • The largest Palisade Bio seller in Q3 2015 was Credit Suisse, an estimated $1.84M sold.

Based on aggregated 13F filings for Q3 2015.